Hemangiol – Non-selective beta-blocker.
Has antihypertensive, antianginal and antiarrhythmic effects. Due to the blockade of β-adrenergic receptors, it reduces the formation of cAMP from ATP stimulated by catecholamines, as a result of which it reduces the intracellular supply of calcium ions, has a negative chrono-, dromo-, bathmo- and inotropic effect (reduces heart rate, inhibits conductivity and excitability, reduces myocardial contractility).
Arterial hypertension; angina pectoris, unstable angina; sinus tachycardia (including in hyperthyroidism), supraventricular tachycardia, tachystolic atrial fibrillation, supraventricular and ventricular extrasystole, essential tremor, migraine prevention, alcohol withdrawal (agitation and tremor), anxiety, pheochromocytoma (adjuvant treatment), diffuse toxic goiter and thyrotoxic crisis (as an adjuvant, including in cases of intolerance to antithyroid drugs), sympathoadrenal crises against the background of diencephalic syndrome.
Proliferating infantile hemangioma requiring systemic therapy: hemangioma that is life-threatening or has a negative effect on the functioning of body systems; ulcerative hemangioma characterized by pain and/or failure to respond to previous treatments for ulceration; hemangioma with potential for permanent scarring or deformity.
Active ingredient: propranolol hydrochloride
Prescription medicine